Interferon α or β: which is the culprit in autoimmune disease?

Type I interferons contribute to the pathogenesis of several autoimmune diseases, with each interferon being preferentially produced in different settings by different cells. Could knowing which one is predominant in a given disease - or patient - lead to better therapies?